Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Vaxart Inc (VXRT)

Vaxart Inc (VXRT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 601,789
  • Shares Outstanding, K 117,767
  • Annual Sales, $ 4,050 K
  • Annual Income, $ -32,220 K
  • 60-Month Beta 0.02
  • Price/Sales 155.72
  • Price/Cash Flow N/A
  • Price/Book 4.81
Trade VXRT with:

Options Overview

Details
  • Implied Volatility 93.54%
  • Historical Volatility 63.20%
  • IV Percentile 1%
  • IV Rank 4.40%
  • IV High 328.71% on 02/02/21
  • IV Low 82.72% on 03/31/21
  • Put/Call Vol Ratio 0.08
  • Today's Volume 2,081
  • Volume Avg (30-Day) 5,097
  • Put/Call OI Ratio 0.33
  • Today's Open Interest 79,723
  • Open Int (30-Day) 97,955

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/21
See More
  • Average Estimate -0.10
  • Number of Estimates 2
  • High Estimate -0.08
  • Low Estimate -0.12
  • Prior Year -0.02
  • Growth Rate Est. (year over year) -400.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.86 +3.46%
on 04/20/21
7.17 -29.85%
on 03/22/21
-1.85 (-26.89%)
since 03/19/21
3-Month
4.86 +3.46%
on 04/20/21
24.90 -79.80%
on 02/02/21
-2.02 (-28.65%)
since 01/20/21
52-Week
2.23 +125.56%
on 06/09/20
24.90 -79.80%
on 02/02/21
+2.66 (+112.24%)
since 04/20/20

Most Recent Stories

More News
The Need for Comprehensive Diagnostics Remains as Cases Spike Once More

, /PRNewswire/ -- The Director of the U.S. National Institute of Allergy and Infectious Diseases, Dr. , and many other experts have warned that rapid reopening and lifting of pandemic restrictions in...

FLDM : 4.35 (-4.81%)
VXRT : 4.99 (-2.35%)
SBFM : 0.1270 (-7.03%)
BNTX : 149.14 (-0.23%)
VIR : 47.80 (+1.23%)
Effective Diagnostics Help to Tame the Spread of the Pandemic

, /PRNewswire/ -- Recent reports from across the country clearly show that infection cases are stabilizing. Additionally, vaccines are being administrated at an effective rate, which contributes to a...

TOMDF : 0.0540 (-6.09%)
BNTX : 149.14 (-0.23%)
DVAX : 9.61 (-11.75%)
VIR : 47.80 (+1.23%)
VXRT : 4.99 (-2.35%)
Diagnostic Improvements Play a Key Role in the Abatement of the Pandemic

, /PRNewswire/ -- Since the pandemic's inception and the subsequent pressure the healthcare infrastructure faced, effective mass testing has been necessary to come up with a proper plan to reduce case...

TOMDF : 0.0540 (-6.09%)
SRNE : 7.45 (-0.53%)
VXRT : 4.99 (-2.35%)
ABT : 119.87 (-3.74%)
OPK : 4.14 (-1.43%)
Vaxart to Present at the H.C. Wainwright Global Life Sciences Conference

Vaxart, Inc. (Nasdaq: VXRT), a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, today announced that management will present...

VXRT : 4.99 (-2.35%)
NASDAQ Drops Another 2.7% as Bond Yields Rise Again

NASDAQ Drops Another 2.7% as Bond Yields Rise Again

SAIL : 47.60 (-0.15%)
MMSI : 61.57 (+1.00%)
RDUS : 18.99 (+0.48%)
TTD : 677.12 (-2.64%)
BJ : 44.18 (-0.56%)
NVAX : 208.90 (-5.69%)
PRIM : 33.27 (-3.14%)
CAR : 73.54 (-5.90%)
MNKD : 4.24 (+1.92%)
ZUMZ : 42.21 (-4.76%)
TVTX : 25.26 (+1.77%)
GH : 149.01 (-2.56%)
VXRT : 4.99 (-2.35%)
QDEL : 119.60 (-2.22%)
PLAN : 57.67 (-1.18%)
NFLX : 547.76 (-1.20%)
AAPL : 133.56 (-0.95%)
AMZN : 3,328.20 (-1.30%)
GOOG : 2,292.00 (-0.45%)
FB : 299.86 (-0.79%)
MSFT : 258.01 (-0.28%)
Vaxart, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / March 2, 2021 / Vaxart, Inc. (NASDAQ:VXRT) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on March 2, 2021 at 4:30 PM Eastern...

VXRT : 4.99 (-2.35%)
VAXART, INC. (VXRT) Moves 5.6% Higher: Will This Strength Last?

VAXART, INC. (VXRT) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the...

VXRT : 4.99 (-2.35%)
NASDAQ Plunges 3.5% as Bond Yields Spike

NASDAQ Plunges 3.5% as Bond Yields Spike

CVX : 101.29 (-1.91%)
INFN : 9.24 (-3.75%)
INSG : 8.38 (-3.23%)
ESTC : 120.12 (-2.45%)
SHOP : 1,118.08 (-2.42%)
TLND : 63.96 (+0.02%)
NTCT : 28.04 (-1.96%)
CVA : 13.25 (-1.71%)
SQ : 247.00 (+0.68%)
VXRT : 4.99 (-2.35%)
PRPL : 33.37 (-3.64%)
AVID : 19.50 (-5.71%)
TWLO : 364.82 (-0.72%)
FB : 299.86 (-0.79%)
AAPL : 133.56 (-0.95%)
AMZN : 3,328.20 (-1.30%)
GOOG : 2,292.00 (-0.45%)
TSLA : 715.63 (+0.14%)
MSFT : 258.01 (-0.28%)
Vaxart Provides Business Update and Reports Fourth Quarter and Full Year 2020 Financial Results

Vaxart, Inc. (Nasdaq: VXRT) a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, today announced that it plans to initiate...

VXRT : 4.99 (-2.35%)
Vaxart to Provide 2021 Business Outlook on Tuesday, March 2, 2021

Vaxart, Inc., a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, today announced that it will host a conference call and...

VXRT : 4.99 (-2.35%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell and ranks in the Top 1% of all short term signal directions.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Vaxart, Inc. is a clinical-stage company developing a range of oral recombinant vaccines based on its proprietary delivery platform. The company's vaccines are administered using convenient room temperature-stable tablets that can be stored and shipped without refrigeration and eliminate risk of needle-stick...

See More

Key Turning Points

3rd Resistance Point 5.77
2nd Resistance Point 5.62
1st Resistance Point 5.37
Last Price 4.99
1st Support Level 4.96
2nd Support Level 4.81
3rd Support Level 4.55

See More

52-Week High 24.90
Fibonacci 61.8% 16.24
Fibonacci 50% 13.56
Fibonacci 38.2% 10.89
Last Price 4.99
52-Week Low 2.23

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar